Literature DB >> 8873295

Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes.

U Halbreich1, S Palter.   

Abstract

Osteoporosis, a very prevalent, potentially debilitating disease, is characterized by decreased bone mineral density (BMD). Decreased BMD has recently been reported in patients suffering from several mental disorders, including schizophrenia and major depression. In these patients the accelerated decrease in BMD can be attributed to drug-induced decreases in levels of estrogen and testosterone, to polydipsia and decreased calcium to smoking and alcoholism, and to increased activity of several interleukins as well as to hyperprolactinemia and hypercortisolemia. Several of these processes may be prevented or altered in order to prevent or delay decreased BMD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8873295     DOI: 10.1093/schbul/22.3.447

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  22 in total

Review 1.  Antipsychotic treatment for late-life schizophrenia.

Authors:  Jeremy A Sable; Dilip V Jeste
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

Review 2.  Dose response and atypical antipsychotics in schizophrenia.

Authors:  Bruce J Kinon; Jonna Ahl; Virginia L Stauffer; Angela L Hill; Peter F Buckley
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 3.  Minireview: A skeleton in serotonin's closet?

Authors:  Masanobu Kawai; Clifford J Rosen
Journal:  Endocrinology       Date:  2010-07-21       Impact factor: 4.736

4.  Long-term mental distress, bone mineral density and non-vertebral fractures. The Tromsø Study.

Authors:  A J Søgaard; R M Joakimsen; A Tverdal; V Fønnebø; J H Magnus; G K R Berntsen
Journal:  Osteoporos Int       Date:  2004-12-24       Impact factor: 4.507

Review 5.  Emerging therapeutic opportunities for skeletal restoration.

Authors:  Masanobu Kawai; Ulrike I Mödder; Sundeep Khosla; Clifford J Rosen
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

6.  Association of depressive symptoms and anxiety with bone mass and density in ever-smoking and never-smoking adolescent girls.

Authors:  Lorah D Dorn; Elizabeth J Susman; Stephanie Pabst; Bin Huang; Heidi Kalkwarf; Susannah Grimes
Journal:  Arch Pediatr Adolesc Med       Date:  2008-12

7.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

Authors:  Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

8.  Risperidone-associated prolactin elevation and markers of bone turnover during acute treatment.

Authors:  Jeffrey R Bishop; Leah H Rubin; James L Reilly; Mani N Pavuluri; John A Sweeney
Journal:  Ther Adv Psychopharmacol       Date:  2012-06

9.  Decreased osteoprotegerin and increased bone turnover in young female patients with major depressive disorder and a lifetime history of anorexia nervosa.

Authors:  Kai G Kahl; Sebastian Rudolf; Leif Dibbelt; Beate M Stoeckelhuber; Hans-Björn Gehl; Fritz Hohagen; Ulrich Schweiger
Journal:  Osteoporos Int       Date:  2004-08-05       Impact factor: 4.507

10.  Age-related increases in parathyroid hormone may be antecedent to both osteoporosis and dementia.

Authors:  Eric R Braverman; Thomas J H Chen; Amanda L C Chen; Vanessa Arcuri; Mallory M Kerner; Anish Bajaj; Javier Carbajal; Dasha Braverman; B William Downs; Kenneth Blum
Journal:  BMC Endocr Disord       Date:  2009-10-13       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.